Search for: "Application of Andrews"
Results 241 - 260
of 4,748
Sorted by Relevance
|
Sort by Date
1 Aug 2017, 10:37 am
Andrews v. [read post]
26 Jan 2011, 4:06 pm
An interesting piece in the Guardian on 18 January focused on a letter sent recently by Carter Ruck to the Soil Association warning of potential liability under libel law if an objection to a planning application was not withdrawn. [read post]
28 May 2010, 1:34 pm
SPEs David Ometz, John Cottingham and Andrew Koenig, who were interviewed for the article, were spot on in their suggestions for examiners and attorneys to find common ground and work together so deserving applicants can get their patents and their innovations to market. [read post]
21 Dec 2022, 12:30 pm
appeared first on Andrew Flusche. [read post]
12 Dec 2020, 3:18 pm
Check out the application instructions here. [read post]
22 Oct 2021, 7:35 am
And yet, insurers have denied, and continue to uniformly deny COVID-19-related business income claims without regard for the facts, policy wording or applicable state law. [read post]
17 Sep 2015, 4:58 pm
In short, although the number of defamation claims is unexpectedly up, it will take time for the impact of the new law to be judged Andrew Stephenson is a consultant solicitor at Hamlins LLP, who acted for Vladimir Sloutsker [read post]
27 Mar 2020, 10:29 am
Andrews in Rondevoo Technologies, LLC v. [read post]
26 Feb 2009, 9:51 am
Ex- Celtic House guru Andrew Waitman has been quietly building his next empire over at The Pythian Group, where he assumed the CEO role last October. [read post]
9 Apr 2016, 8:13 pm
In this presentation, Patent Docs author and MBHB attorney Andrew Williams, Ph.D. and MBHB attorney James Lovsin will provide: • A review of the PTAB cases in which the Federal Circuit has vacated and remanded in order to determine best practices for appealing an adverse final written decision; • A look at the application of the "Broadest... [read post]
9 Jun 2021, 10:00 pm
This new guidance comes on the heels of Governor Andrew Cuomo’s recent announcement that once 70% of adult New Yorkers have received at least the first dose of the COVID-19 vaccine, almost all applicable guidance will become optional, except that unvaccinated individuals still need to wear face coverings and maintain social distancing. [read post]
26 Oct 2016, 9:59 pm
It was with this understanding that the Patent Office promulgated rules making the Federal Rules of Evidence applicable to these proceedings. [read post]
14 Sep 2017, 9:17 pm
By Andrew Williams -- Earlier today, the U.S. [read post]
9 Jun 2021, 10:00 pm
This new guidance comes on the heels of Governor Andrew Cuomo’s recent announcement that once 70% of adult New Yorkers have received at least the first dose of the COVID-19 vaccine, almost all applicable guidance will become optional, except that unvaccinated individuals still need to wear face coverings and maintain social distancing. [read post]
28 Jul 2014, 10:53 am
Governor Andrew Cuomo signed the bill last Tuesday. [read post]
6 Jun 2017, 9:04 pm
By Andrew Williams -- On May 25, 2017, the FDA's Oncologic Drug Advisory Committee recommended approval of biologics license application ("BLA") 125545 submitted by Hospira Inc., a Pfizer company, for Retacrit, a proposed biosimilar to Amgen Inc.'s Epogen/Procrit (epoetin alfa). [read post]
13 Nov 2020, 4:05 am
Yesterday, an Emergency Application for Writ of Injunction (full text) was filed by the Catholic Diocese of Brooklyn in its challenge to New York Governor Andrew Cuomo's limitations on the number of persons who can attend a worship service during the COVID-19 pandemic. [read post]
24 Sep 2017, 9:21 pm
Mylan because the first prong was no longer applicable in view of the Supreme Court's TC Heartland LLC v. [read post]
8 Aug 2015, 9:00 pm
Andrew W. [read post]
9 Feb 2016, 6:37 pm
By Andrew Williams -- Earlier today, the FDA's Arthritis Advisory Committee recommended approval of biologics license application ("BLA") 125544 submitted by Celltrion, Inc. for CT-P13, a proposed biosimilar to Janssen Biotech Inc.'s REMICADE (infliximab) anti-TNF-α antibody. [read post]
